Literature DB >> 21512164

Tetrahydrobiopterin deficiency and nitric oxide synthase uncoupling contribute to atherosclerosis induced by disturbed flow.

Li Li1, Wei Chen, Amir Rezvan, Hanjoong Jo, David G Harrison.   

Abstract

OBJECTIVE: Tetrahydrobiopterin (BH(4)) is a critical cofactor for nitric oxide (NO) synthesis by NO synthase (NOS). Recently, we demonstrated that disturbed flow produced by partial carotid ligation decreases BH(4) levels in vivo. We therefore aimed to determine whether atherosclerosis induced by disturbed flow is due to BH(4) deficiency and NOS uncoupling and whether increasing BH(4) would prevent endothelial dysfunction, plaque inflammation, and atherosclerosis. METHODS AND
RESULTS: We produced a region of disturbed flow in apolipoprotein E(-/-) mice using partial carotid ligation and fed these animals a high-fat diet. This caused endothelial NOS uncoupling as characterized by increased vascular superoxide production, altered vascular reactivity, and a change in endothelial NOS migration on low-temperature gel. These perturbations were accompanied by severe atherosclerosis, infiltration of T cells and macrophages, and an increase in cytokine production. Treatment with BH(4) recoupled NOS, decreased superoxide production, improved endothelium-dependent vasodilatation, and virtually eliminated atherosclerosis. BH(4) treatment also markedly reduced vascular inflammation and improved the cytokine milieu induced by disturbed flow.
CONCLUSIONS: Our results highlight a key role of BH(4) deficiency and NOS uncoupling in atherosclerosis induced by disturbed flow and provide insight into the effect of modulating vascular BH(4) levels on atherosclerosis and inflammation at these sites of the circulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512164      PMCID: PMC3117114          DOI: 10.1161/ATVBAHA.111.226456

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

2.  Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice.

Authors:  Yoshiyuki Hattori; Sachiko Hattori; Xi Wang; Hiroko Satoh; Nobuo Nakanishi; Kikuo Kasai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-01       Impact factor: 8.311

3.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

Authors:  E Stroes; J Kastelein; F Cosentino; W Erkelens; R Wever; H Koomans; T Lüscher; T Rabelink
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 4.  Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.

Authors:  Keith M Channon
Journal:  Trends Cardiovasc Med       Date:  2004-11       Impact factor: 6.677

5.  Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction.

Authors:  C A Gunnett; D D Lund; A K McDowell; F M Faraci; D D Heistad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-02       Impact factor: 8.311

6.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels.

Authors:  J N Wilcox; R R Subramanian; C L Sundell; W R Tracey; J S Pollock; D G Harrison; P A Marsden
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

7.  Hemodynamic shear stresses in mouse aortas: implications for atherogenesis.

Authors:  Jin Suo; Dardo E Ferrara; Dan Sorescu; Robert E Guldberg; W Robert Taylor; Don P Giddens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11-22       Impact factor: 8.311

Review 8.  Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior.

Authors:  Yiannis S Chatzizisis; Ahmet Umit Coskun; Michael Jonas; Elazer R Edelman; Charles L Feldman; Peter H Stone
Journal:  J Am Coll Cardiol       Date:  2007-06-08       Impact factor: 24.094

9.  Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension.

Authors:  C M Boulanger; C Heymes; J Benessiano; R S Geske; B I Lévy; P M Vanhoutte
Journal:  Circ Res       Date:  1998 Dec 14-28       Impact factor: 17.367

10.  Regulation of tetrahydrobiopterin biosynthesis by shear stress.

Authors:  Julian D Widder; Wei Chen; Li Li; Sergey Dikalov; Beat Thöny; Kazuyuki Hatakeyama; David G Harrison
Journal:  Circ Res       Date:  2007-08-17       Impact factor: 17.367

View more
  28 in total

Review 1.  Differential metabolic actions of specific statins: clinical and therapeutic considerations.

Authors:  Soo Lim; Ichiro Sakuma; Michael J Quon; Kwang Kon Koh
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 2.  Vascular Adaptation to Exercise in Humans: Role of Hemodynamic Stimuli.

Authors:  Daniel J Green; Maria T E Hopman; Jaume Padilla; M Harold Laughlin; Dick H J Thijssen
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

3.  Dynamic immune cell accumulation during flow-induced atherogenesis in mouse carotid artery: an expanded flow cytometry method.

Authors:  Noah Alberts-Grill; Amir Rezvan; Dong Ju Son; Haiwei Qiu; Chan Woo Kim; Melissa L Kemp; Cornelia M Weyand; Hanjoong Jo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-12       Impact factor: 8.311

Review 4.  Oxidative Stress and Hypertensive Diseases.

Authors:  Roxana Loperena; David G Harrison
Journal:  Med Clin North Am       Date:  2016-10-27       Impact factor: 5.456

5.  Modeling of biopterin-dependent pathways of eNOS for nitric oxide and superoxide production.

Authors:  Saptarshi Kar; Mahendra Kavdia
Journal:  Free Radic Biol Med       Date:  2011-07-08       Impact factor: 7.376

Review 6.  Ascorbic acid repletion: A possible therapy for diabetic macular edema?

Authors:  James M May
Journal:  Free Radic Biol Med       Date:  2016-02-17       Impact factor: 7.376

7.  Phage-display-guided nanocarrier targeting to atheroprone vasculature.

Authors:  Lucas H Hofmeister; Sue Hyun Lee; Allison E Norlander; Kim Ramil C Montaniel; Wei Chen; David G Harrison; Hak-Joon Sung
Journal:  ACS Nano       Date:  2015-03-23       Impact factor: 15.881

Review 8.  Role of vitamin C in the function of the vascular endothelium.

Authors:  James M May; Fiona E Harrison
Journal:  Antioxid Redox Signal       Date:  2013-05-29       Impact factor: 8.401

Review 9.  Blood pressure regulation VIII: resistance vessel tone and implications for a pro-atherogenic conduit artery endothelial cell phenotype.

Authors:  Jaume Padilla; Nathan T Jenkins; M Harold Laughlin; Paul J Fadel
Journal:  Eur J Appl Physiol       Date:  2013-07-17       Impact factor: 3.078

10.  ASSOCIATIONS BETWEEN ACCELERATED ATHEROSCLEROSIS, OXIDIZED LDL IMMUNE COMPLEXES, AND IN VITRO ENDOTHELIAL DYSFUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  Jim C Oates; Viswanathan Ramakrishnan; Paul J Nietert; J David Spence; Thomas W Fleury; Margaret Markiewicz; Dayvia L Russell; Maria F Lopes-Virella
Journal:  Trans Am Clin Climatol Assoc       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.